MRK

#40
Merck & Co., Inc.
119.75 USD
-0.39%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
119.58
119.91
Rango anual
73.31
125.14
Cambio diario
-0.39%
Variación mensual
+3.82%
Variación en los últimos 6 meses
+41.98%
Cambio anual
+50.63%
Cierres anteriores
120.22
Abrir
119.58
Bid
Ask
Mínimo
119.58
High
119.91
Volumen
2 279
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 296.07 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
14.46
Relación precio/flujo de caja
4.06
Dividendos por acción
3.28
Rendimiento por dividendo, %
3.12

Merck & Company Inc (new)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

Noticias